Mineralocorticoid Receptor in Myeloid Cells Mediates Angiotensin II-Induced Vascular Dysfunction in Female Mice.

adipose tissue arterial stiffening endothelium inflammation macrophage

Journal

Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006

Informations de publication

Date de publication:
2021
Historique:
received: 28 07 2020
accepted: 17 02 2021
entrez: 15 4 2021
pubmed: 16 4 2021
medline: 16 4 2021
Statut: epublish

Résumé

Enhanced mineralocorticoid receptor (MR) signaling is critical to the development of endothelial dysfunction and arterial stiffening. However, there is a lack of knowledge about the role of MR-induced adipose tissue inflammation in the genesis of vascular dysfunction in women. In this study, we hypothesize that MR activation in myeloid cells contributes to angiotensin II (Ang II)-induced aortic stiffening and endothelial dysfunction in females

Identifiants

pubmed: 33854438
doi: 10.3389/fphys.2021.588358
pmc: PMC8039313
doi:

Types de publication

Journal Article

Langues

eng

Pagination

588358

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL132012
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL088105
Pays : United States
Organisme : BLRD VA
ID : I01 BX003391
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL142770
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL124155
Pays : United States
Organisme : BLRD VA
ID : I01 BX001981
Pays : United States

Informations de copyright

Copyright © 2021 Manrique-Acevedo, Padilla, Naz, Woodford, Ghiarone, Aroor, Hulse, Cabral-Amador, Martinez-Diaz, Hans, Whaley-Connell, Martinez-Lemus and Lastra.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Hypertension. 2013 Dec;62(6):1105-10
pubmed: 24060894
Endocrinology. 2016 Apr;157(4):1590-600
pubmed: 26872089
Stroke. 2011 Jan;42(1):179-85
pubmed: 21106954
Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):195-200
pubmed: 16368758
J Clin Invest. 2017 Jan 3;127(1):1-4
pubmed: 28045402
Metabolism. 2018 Aug;85:76-89
pubmed: 29530798
Cardiovasc Res. 2017 Jul 1;113(9):999-1008
pubmed: 28582523
J Am Heart Assoc. 2018 Feb 16;7(4):
pubmed: 29453308
Br J Pharmacol. 2017 Oct;174(20):3496-3513
pubmed: 28063251
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Cardiovasc Drugs Ther. 2018 Oct;32(5):503-510
pubmed: 30097828
Endocrinology. 2017 Oct 1;158(10):3592-3604
pubmed: 28977602
Biomed Res Int. 2015;2015:652738
pubmed: 26448944
Front Nutr. 2016 Apr 19;3:10
pubmed: 27148535
Curr Hypertens Rep. 2018 May 7;20(5):44
pubmed: 29736674
Hypertension. 2019 Feb;73(2):458-468
pubmed: 30624990
J Am Soc Nephrol. 2014 Oct;25(10):2231-40
pubmed: 24700867
Front Immunol. 2014 Sep 26;5:470
pubmed: 25309549
Horm Mol Biol Clin Investig. 2015 Apr;22(1):19-26
pubmed: 25941914
Hypertension. 2019 Dec;74(6):1409-1419
pubmed: 31630572
PLoS One. 2014 Oct 29;9(10):e110950
pubmed: 25354087
Am J Physiol Regul Integr Comp Physiol. 2002 Dec;283(6):R1442-9
pubmed: 12388474
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1621-30
pubmed: 24833795
J Lipid Res. 2018 May;59(5):784-794
pubmed: 29599420
Acta Pharmacol Sin. 2010 Oct;31(10):1324-8
pubmed: 20835265
Am J Physiol Endocrinol Metab. 2019 Dec 1;317(6):E1140-E1149
pubmed: 31638856
Diabetes. 2016 Aug;65(8):2392-403
pubmed: 27207514
Curr Hypertens Rep. 2016 Nov;18(11):82
pubmed: 27787838
Front Pharmacol. 2017 May 29;8:313
pubmed: 28611666
Am J Physiol Regul Integr Comp Physiol. 2013 Apr 1;304(7):R543-52
pubmed: 23389108
Nat Rev Cardiol. 2019 Feb;16(2):83-99
pubmed: 30287946
Endocrinology. 2019 Dec 1;160(12):2918-2928
pubmed: 31617909
Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):3012-23
pubmed: 23087364
Cardiovasc Drugs Ther. 2018 Oct;32(5):481-502
pubmed: 30171461
J Physiol. 2015 Apr 15;593(8):1931-43
pubmed: 25627876
Physiol Rev. 2019 Jan 1;99(1):311-379
pubmed: 30379623
Cardiovasc Res. 2001 Aug 1;51(2):351-8
pubmed: 11470475
Am J Physiol Endocrinol Metab. 2019 Feb 1;316(2):E156-E167
pubmed: 30512987
J Am Soc Nephrol. 2000 Oct;11(10):1807-12
pubmed: 11004210
Hypertension. 2018 Jun;71(6):1083-1090
pubmed: 29686001
J Clin Invest. 2004 Jun;113(11):1530-2
pubmed: 15173878
J Biol Chem. 2013 Feb 8;288(6):4174-93
pubmed: 23255592
Circulation. 2016 Mar 1;133(9):916-47
pubmed: 26811316
J Transl Med. 2013 Jan 05;11:3
pubmed: 23289368
J Obes. 2011;2011:490650
pubmed: 21403826
Endocrinology. 2000 Oct;141(10):3871-8
pubmed: 11014244
Curr Hypertens Rep. 2018 Aug 14;20(10):88
pubmed: 30109433
Front Immunol. 2020 Aug 06;11:1974
pubmed: 32849660
Diabetes. 2015 Aug;64(8):2836-46
pubmed: 25845662
J Clin Invest. 2010 Sep;120(9):3350-64
pubmed: 20697155
JAMA. 2012 Sep 5;308(9):875-81
pubmed: 22948697
Hypertension. 2011 Oct;58(4):588-95
pubmed: 21859964
Hypertension. 2009 Sep;54(3):537-43
pubmed: 19635989
Hypertension. 2006 Dec;48(6):1058-65
pubmed: 17060506
Br J Pharmacol. 1999 Jan;126(1):219-26
pubmed: 10051139
Circulation. 2007 Jul 3;116(1):39-48
pubmed: 17576866
Front Endocrinol (Lausanne). 2013 Oct 29;4:161
pubmed: 24194732
Am J Physiol Regul Integr Comp Physiol. 2017 Aug 1;313(2):R67-R77
pubmed: 28539355
Endocrinology. 2019 Sep 1;160(9):2101-2114
pubmed: 31373631
Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1617-22
pubmed: 15933248
Cardiovasc Res. 2017 Jul 1;113(9):1055-1063
pubmed: 28838041
Hypertension. 2017 Oct;70(4):780-789
pubmed: 28760942
Physiol Rep. 2015 Jul;3(7):
pubmed: 26197933
Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):212-223
pubmed: 30580570
Diabetes Care. 2003 Feb;26(2):372-9
pubmed: 12547865
Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1425-37
pubmed: 21765057
PLoS One. 2015 Mar 06;10(3):e0119533
pubmed: 25745858
Brain. 2008 Nov;131(Pt 11):3019-33
pubmed: 18819987
Atherosclerosis. 2014 Dec;237(2):381-90
pubmed: 25463062
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1458-64
pubmed: 19608970
J Clin Endocrinol Metab. 2013 Jan;98(1):E17-24
pubmed: 23118428
Front Physiol. 2021 Jan 15;11:628101
pubmed: 33519529
Circulation. 2010 Feb 2;121(4):505-11
pubmed: 20083680
Pharmacol Rev. 2016 Jan;68(1):49-75
pubmed: 26668301

Auteurs

Camila Manrique-Acevedo (C)

Division of Endocrinology and Metabolism, Department of Medicine, University of Missouri, Columbia, MO, United States.
Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, United States.
Research Service, Harry S. Truman Memorial Veterans' Hospital, Columbia, MO, United States.

Jaume Padilla (J)

Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, United States.
Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO, United States.

Huma Naz (H)

Division of Endocrinology and Metabolism, Department of Medicine, University of Missouri, Columbia, MO, United States.
Research Service, Harry S. Truman Memorial Veterans' Hospital, Columbia, MO, United States.

Makenzie L Woodford (ML)

Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, United States.
Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO, United States.

Thaysa Ghiarone (T)

Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, United States.

Annayya R Aroor (AR)

Division of Endocrinology and Metabolism, Department of Medicine, University of Missouri, Columbia, MO, United States.
Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, United States.

Jack L Hulse (JL)

Division of Endocrinology and Metabolism, Department of Medicine, University of Missouri, Columbia, MO, United States.

Francisco J Cabral-Amador (FJ)

Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, United States.

Vanesa Martinez-Diaz (V)

Division of Endocrinology and Metabolism, Department of Medicine, University of Missouri, Columbia, MO, United States.

Chetan P Hans (CP)

Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, United States.
Division of Cardiovascular Medicine, Department of Medicine, University of Missouri, Columbia, MO, United States.

Adam Whaley-Connell (A)

Division of Endocrinology and Metabolism, Department of Medicine, University of Missouri, Columbia, MO, United States.
Research Service, Harry S. Truman Memorial Veterans' Hospital, Columbia, MO, United States.
Division of Nephrology and Hypertension, Department of Medicine, University of Missouri, Columbia, MO, United States.

Luis A Martinez-Lemus (LA)

Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, United States.
Department of Biomedical, Biological and Chemical Engineering, University of Missouri, Columbia, MO, United States.
Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO, United States.

Guido Lastra (G)

Division of Endocrinology and Metabolism, Department of Medicine, University of Missouri, Columbia, MO, United States.
Research Service, Harry S. Truman Memorial Veterans' Hospital, Columbia, MO, United States.

Classifications MeSH